KAM

Krensavage Asset Management Portfolio holdings

AUM $235M
1-Year Est. Return 42.5%
This Quarter Est. Return
1 Year Est. Return
+42.5%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$235M
AUM Growth
+$45.8M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
18
New
Increased
Reduced
Closed

Top Buys

1
+$22M
2
+$8.26M
3
+$1.4M
4
EXEL icon
Exelixis
EXEL
+$1.03M
5
VNDA icon
Vanda Pharmaceuticals
VNDA
+$776K

Top Sells

1
+$15.3M
2
+$9.42M
3
+$6.11M
4
SUPN icon
Supernus Pharmaceuticals
SUPN
+$5.2M
5
UTHR icon
United Therapeutics
UTHR
+$1.47M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UTHR icon
1
United Therapeutics
UTHR
$21.3B
$40.9M 17.44%
97,646
-3,500
ENTA icon
2
Enanta Pharmaceuticals
ENTA
$426M
$25.3M 10.78%
2,114,444
JAZZ icon
3
Jazz Pharmaceuticals
JAZZ
$10.2B
$22.1M 9.42%
167,816
+3,000
BMRN icon
4
BioMarin Pharmaceuticals
BMRN
$10.1B
$22M 9.36%
+405,450
EXEL icon
5
Exelixis
EXEL
$10.9B
$21.4M 9.12%
518,526
+25,000
SUPN icon
6
Supernus Pharmaceuticals
SUPN
$2.71B
$17.4M 7.4%
363,479
-108,897
SNY icon
7
Sanofi
SNY
$118B
$15.3M 6.51%
323,946
+175,000
AVDL
8
Avadel Pharmaceuticals
AVDL
$2.1B
$14.6M 6.22%
955,860
-3,017
GSK icon
9
GSK
GSK
$98.4B
$11.7M 5%
271,729
CAH icon
10
Cardinal Health
CAH
$47B
$11.6M 4.93%
73,745
-60,000
INDV icon
11
Indivior
INDV
$4.52B
$8.19M 3.49%
339,532
-634,942
BNTX icon
12
BioNTech
BNTX
$22.8B
$7.83M 3.33%
79,366
+5,984
ALKS icon
13
Alkermes
ALKS
$4.76B
$6.24M 2.66%
207,822
VNDA icon
14
Vanda Pharmaceuticals
VNDA
$375M
$5.89M 2.51%
1,180,388
+155,505
REGN icon
15
Regeneron Pharmaceuticals
REGN
$77.5B
$2.25M 0.96%
4,000
BIIB icon
16
Biogen
BIIB
$25.5B
$1.4M 0.6%
+10,000
EOLS icon
17
Evolus
EOLS
$450M
$614K 0.26%
+100,000
JNJ icon
18
Johnson & Johnson
JNJ
$508B
– –
-40,000